Authors
Loading...
Does not yet alter beta-blocker selection; leaves open whether nebivolol's nitric oxide effects reduce thrombotic risk.
Key points are not available for this paper at this time.
Falciani et al. (2001) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: